{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:24:11Z","timestamp":1772202251284,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6784","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1038\/35012636","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:45:45Z","timestamp":1027673145000},"page":"360-364","source":"Crossref","is-referenced-by-count":900,"title":["Neurotoxicity induces cleavage of p35 to p25 by calpain"],"prefix":"10.1038","volume":"405","author":[{"given":"Ming-sum","family":"Lee","sequence":"first","affiliation":[]},{"given":"Young T.","family":"Kwon","sequence":"additional","affiliation":[]},{"given":"Mingwei","family":"Li","sequence":"additional","affiliation":[]},{"given":"Junmin","family":"Peng","sequence":"additional","affiliation":[]},{"given":"Robert M.","family":"Friedlander","sequence":"additional","affiliation":[]},{"given":"Li-Huei","family":"Tsai","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF35012636_CR1","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.1073\/pnas.93.20.11173","volume":"93","author":"T Ohshima","year":"1996","unstructured":"Ohshima, T.  et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11173\u2013 11178 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35012636_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0896-6273(01)80044-1","volume":"18","author":"T Chae","year":"1997","unstructured":"Chae, T. et al. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron  18, 29\u201342 ( 1997).","journal-title":"Neuron"},{"key":"BF35012636_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1101\/gad.10.7.816","volume":"10","author":"M Nikolic","year":"1996","unstructured":"Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F. & Tsai, L. H. The cdk5\/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816\u2013825 (1996).","journal-title":"Genes Dev."},{"key":"BF35012636_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/45159","volume":"402","author":"GN Patrick","year":"1999","unstructured":"Patrick, G. N.  et al. Conversion of p35 to p25 de-regulates cdk5 activity and promotes neurodegeneration. Nature 402, 615\u2013 622 (1999).","journal-title":"Nature"},{"key":"BF35012636_CR5","first-page":"77","volume-title":"Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease","author":"KKW Wang","year":"1999","unstructured":"Wang, K. K. W. in  Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease (eds Wang, K. K. W. & Yuen, P.-W.) 77\u2013102 (Taylor & Francis, Philadelphia, 1999)."},{"key":"BF35012636_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/bj3280721","volume":"328","author":"H Sorimachi","year":"1997","unstructured":"Sorimachi, H., Ishiura, S. & Suzuki, K. Structure and physiological function of calpains.  Biochem. J. 328, 721\u2013732 (1997).","journal-title":"Biochem. J."},{"key":"BF35012636_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/371423a0","volume":"371","author":"J Lew","year":"1994","unstructured":"Lew, J. et al. A brain-specific activator of cyclin-dependent kinase 5.  Nature 371, 423\u2013426 ( 1994).","journal-title":"Nature"},{"key":"BF35012636_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","volume":"16","author":"BA Yankner","year":"1996","unstructured":"Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron  16, 921\u2013932 ( 1996).","journal-title":"Neuron"},{"key":"BF35012636_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0014-5793(99)01279-X","volume":"459","author":"A Alvarez","year":"1999","unstructured":"Alvarez, A., Toro, R., Caceres, A. & Maccioni, R. B. Inhibition of tau phosphorylating protein kinase cdk5 prevents \u03b2-amyloid-induced neuronal death. FEBS Lett. 459, 421\u2013 426 (1999).","journal-title":"FEBS Lett."},{"key":"BF35012636_CR10","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.1073\/pnas.90.22.10573","volume":"90","author":"N Arispe","year":"1993","unstructured":"Arispe, N., Pollard, H. B. & Rojas, E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta protein [A beta P-(1-40)] in bilayer membranes.  Proc. Natl Acad. Sci. USA 90, 10573\u2013 10577 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35012636_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1006\/bbrc.1993.1952","volume":"194","author":"H Hartmann","year":"1993","unstructured":"Hartmann, H., Eckert, A. & Muller, W. E. \u03b2-Amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochem. Biophys. Res. Commun. 194, 1216\u20131220 ( 1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF35012636_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","volume":"12","author":"MP Mattson","year":"1992","unstructured":"Mattson, M. P.  et al. \u03b2-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376\u2013389 ( 1992).","journal-title":"J. Neurosci."},{"key":"BF35012636_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/phrs.1998.0411","volume":"39","author":"A Pascale","year":"1999","unstructured":"Pascale, A. & Etcheberrigaray, R. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities.  Pharmacol. Res. 39, 81\u201388 (1999).","journal-title":"Pharmacol. Res."},{"key":"BF35012636_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0006-8993(97)00384-3","volume":"763","author":"R Grynspan","year":"1997","unstructured":"Grynspan, R., Griffin, W. R., Cataldo, A., Katayama, S. & Nixon, R. A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763, 145\u2013158 (1997).","journal-title":"Brain Res."},{"key":"BF35012636_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.1994.tb44402.x","volume":"747","author":"RA Nixon","year":"1994","unstructured":"Nixon, R. A.  et al. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747, 77\u201391 (1994).","journal-title":"Ann. NY Acad. Sci."},{"key":"BF35012636_CR16","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K Saito","year":"1993","unstructured":"Saito, K., Elce, J. S., Hamos, J. E. & Nixon, R. A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl Acad. Sci. USA 90, 2628\u2013 2632 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35012636_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(91)90766-O","volume":"561","author":"N Iwamoto","year":"1991","unstructured":"Iwamoto, N., Thangnipon, W., Crawford, C. & Emson, P. C. Localization of calpain immunoreactivity in senile plaques and in neurones undergoing neurofibrillary degeneration in Alzheimer's disease.  Brain Res. 561, 177\u2013180 (1991).","journal-title":"Brain Res."},{"key":"BF35012636_CR18","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1038\/399a023","volume":"399","author":"DJ Selkoe","year":"1999","unstructured":"Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23\u2013A31 (1999).","journal-title":"Nature"},{"key":"BF35012636_CR19","first-page":"454","volume-title":"Brain Energy Metabolism","author":"BK Seisjo","year":"1978","unstructured":"Seisjo, B. K. in  Brain Energy Metabolism 454 (Wiley, New York, 1978)."},{"key":"BF35012636_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/26034","volume":"395","author":"M Nikolic","year":"1998","unstructured":"Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J. & Tsai, L. H. The p35\/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395, 194\u2013198 (1998).","journal-title":"Nature"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/35012636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35012636","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35012636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:57:08Z","timestamp":1684288628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35012636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":20,"journal-issue":{"issue":"6784","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["BF35012636"],"URL":"https:\/\/doi.org\/10.1038\/35012636","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}